What LaVoie Strategic Communications Group does

LaVoie Strategic Communications Group, Inc. is a privately held, SBA-certified women-owned strategic communications firm founded in 2001 by Donna L. LaVoie and headquartered at 10 Post Office Square, Suite 800, Boston, with additional offices in South Florida and New York. The firm operates through two integrated practices — LaVoieHealthScience, serving biotech, medtech, pharmaceutical, and life-sciences organizations, and LaVoieGov, serving federal, state, and regulated public-sector entities — and provides PR, marketing, investor relations, crisis communications, digital/creative, and strategic positioning services. Its core intellectual property consists of five trademarked methodologies: LHS Immersion® (message development and positioning), LHS Fifteen-Slide Presentation® (stakeholder presentation framework), LHS Reach™ (investor relations lifecycle), LHS IR Immersion® (IR analysis for pre-IPO and public companies), and PR4IR™ (integrated PR for IR); both USPTO-registered marks were renewed in April 2026.

The firm runs a senior-led, consultative sales model with no self-service or transactional channel; engagements are delivered through dedicated account teams staffed by practitioners drawn from Genzyme, Alkermes, Millennium (Takeda), BioMarin, Horizon Therapeutics, Ogilvy PR/Feinstein Kean, and Hill+Knowlton. Distribution leverage comes from a 2019 strategic alliance with Omnicom Public Relations Group (DAS Group of Companies, NYSE:OMC), 2023 membership in the IPREX Global PR & Communication Network (100+ markets), GSA Multiple Award Schedule contracting, and the Massachusetts PRF86 statewide contract. Pricing is engagement-based professional services with no publicly disclosed tiers. The firm has executed 350+ client engagements since founding, secured 60+ industry awards (including 11 Bell Ringer Awards, PharmaVoice100, Inc.5000, BBJ Fast 50, and a 2024 PRWeek Best Pharma Product Launch), and was recognized by Boston Business Journal as one of the largest PR firms in Massachusetts.

Name

LaVoie Strategic Communications Group

Legal name

LaVoie Strategic Communications Group, Inc.

Website

https://www.lavoiegroup.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

LaVoie Strategic Communications Group is a Boston-based, women-owned strategic communications firm founded in 2001, operating two practices — LaVoieHealthScience and LaVoieGov — that deliver senior-led PR, investor relations, digital, and crisis communications to biotech, life sciences, and public-sector organizations.

Ownership category

akta.pro rank

Product category

Strategic Communications Services

NAICS

Public Relations Agencies (541820), Public Relations Agencies (54182), Advertising, Public Relations, and Related Services (5418)

SIC

Services-Advertising Agencies (7311), Services-Advertising (7310)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industries

Technology & B2B PR (BPAFADAI), Media Relations & Press Office Services (BPAFADAF), Product & Brand PR (Consumer & B2B) (BPAFADAH), Reputation Management & Online PR (BPAFADAN)

Keywords

• Strategic communications services
• Biotech investor relations
• Life sciences public relations
• Healthcare marketing communications
• Government public relations

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Strategic Communications Advisory Services: Senior-led strategic counsel and integrated communications programs for health, science, and government organizations navigating complex communications challenges, regulatory scrutiny, and public accountability.
2. Strategic Positioning and Messaging: LHS Immersion® methodology for message development, corporate positioning, brand development, and investable storylines for investor audiences, patient and physician groups.
3. Investor Relations Services: Comprehensive IR programming including equity thesis development, investor targeting and outreach, non-deal roadshows, analyst and banker relations, and crisis communications.
4. Public Relations and Marketing: Media strategy, thought leadership development, earned and paid media, social media, digital communications, and advocacy engagement for healthcare and science brands.
5. Government Communications: Public health communications, regulatory and policy communications, stakeholder engagement, and crisis readiness services for federal, state, and regulated government organizations through GSA and state contracts.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Core offering

LaVoie Strategic Communications Group is a Boston-based professional services firm providing senior-led strategic communications, public relations, marketing, and investor relations services to health, science, and government organizations. The firm operates through two integrated practices—LaVoieHealthScience for biotech, medtech, and life sciences clients, and LaVoieGov for federal and state government agencies—and deploys proprietary trademarked methodologies (LHS Immersion®, LHS Fifteen-Slide Presentation®, LHS Reach™, LHS IR Immersion®) for messaging, positioning, and investor communications.

Product overview

LaVoie Strategic Communications Group operates as a strategic communications and marketing firm with two integrated practices: LaVoieHealthScience and LaVoieGov. LaVoieHealthScience focuses on biotech, medtech, and life sciences organizations providing PR & Marketing, IR & Corporate Communications, Digital & Creative, and Strategic Positioning services. LaVoieGov serves federal, state, and regulated government organizations. The firm's proprietary trademarked methodologies—LHS Immersion® for messaging/positioning, LHS Fifteen-Slide Presentation® for investor presentations, LHS Reach™ for investor relations, and LHS IR Immersion® for IR analysis—form the core intellectual property driving their service delivery. Services also include Conference Resource Center support and crisis communications readiness. The company integrates these offerings through senior-led account teams serving emerging through commercial-stage clients.

Differentiator

Problem solved

Functional benefit

Products and services

• LaVoieHealthScience Health and science communications practice providing biotech PR, medtech communications, investor relations, and life sciences marketing services to commercial-stage and emerging healthcare organizations across product launches, commercialization, public and media relations, and corporate communications.
• LaVoieGov Public-sector communications practice providing federal, state, and regulated government organizations with strategic communications for navigating policy, oversight, and stakeholder engagement, including public health communications, regulatory and policy communications, and crisis readiness services.
• Strategic Positioning
• PR & Marketing Public relations and marketing services including media strategy and execution, thought leadership development, social media and digital marketing, and advocacy communications, with specialization in health and science/technology-focused media relations.
• IR & Corporate Communications Investor relations services for public and private companies including financial communications, non-deal roadshows, investor targeting and outreach, analyst and banker relations, investor conferences, investor events, investor branding, and crisis prevention.
• Digital & Creative Full-service digital marketing and creative brand storytelling including social media engagement, SEO, website design and development, video production, animation, infographics, and medical illustrations.
• Issues & Crisis Readiness Crisis communications preparedness including planning, spokesperson training, and rapid-response frameworks designed for high-visibility government and healthcare environments.
• Conference Resource Center Educational resource providing guidance on maximizing investor, scientific, medical, and industry conference impact through strategic planning, materials development, outreach strategies, and follow-up approaches.

Quantifiable outcome

• Newron's share price and market cap increased by over 500% in 9 months
• +5 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered minor and core.

• IPREX Global PR & Communication NetworkminorStrategic or Co-development Partner · 1 January 2023LaVoieHealthScience joined the IPREX Global PR & Communication Network in 2023, connecting independent agencies in more than 100 markets across the globe. Membership provides access to international markets and collaborative opportunities for clients with global needs.
• Omnicom Public Relations Group (DAS Group of Companies)coreStrategic or Co-development Partner · 7 January 2019Strategic alliance formed in January 2019 between LaVoieHealthScience and Omnicom Public Relations Group (a division of Omnicom Group, NYSE:OMC). The alliance provides clients with extended reach and global capabilities while LaVoie maintains its innovative company client base and specialized approach. Alliance cemented to allow LaVoie to remain true to its roots while offering additional thinking and opening key markets for clients as they develop and grow.
• General Services Administration (GSA)coreChannel Partner/ Reseller/ DistributorLaVoieGov holds GSA Multiple Award Schedule (MAS) contract providing federal agencies with streamlined, compliant access to public relations, marketing, and training services under SIN categories 541613, 541810, 541820, 611430, 541910, and 561920.
• Massachusetts PRF86 State ContractcoreChannel Partner/ Reseller/ DistributorLaVoieGov is a holder of the Massachusetts PRF86 statewide contract enabling state agencies and organizations compliant access to communications services.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Canale Communications: San Diego-based boutique communications agency specializing in life sciences, biotech, and medical technology with similar PR, IR, and corporate communications offerings; comparable size, client profile, and senior-led engagement model to LaVoieHealthScience.
• Russo Partners: Specialist healthcare and life sciences communications firm providing IR, public relations, and strategic counsel to biotech, pharma, and medtech clients — directly overlapping LaVoie's core service mix and client segmentation.
• Tiberend Strategic Advisors: Boutique strategic communications and IR firm focused on biotech, life sciences, and healthcare companies; offers media relations, corporate communications, and investor outreach services that closely mirror LaVoie's LaVoieHealthScience practice.
• Westwicke (an ICR company): Healthcare-focused investor relations and strategic communications firm serving life sciences and medical technology companies; integrated into ICR to provide investor relations advisory that closely overlaps LaVoie's LHS Reach™/LHS IR Immersion® offerings.
• 6 Degrees PR: Boutique technology and healthcare public relations firm serving B2B and life sciences clients with media relations, messaging, and analyst/influencer programs; competitor for the mid-market health science and technology communications mandates LaVoie targets.

Broad incumbents

• Health+Commerce (Real Chemistry): Healthcare-focused communications and marketing agency now part of the larger Real Chemistry platform; serves the same biotech, pharma, and health tech client base but with broader integrated marketing, advertising, and PR capabilities at greater scale than LaVoie.
• GCI Health (WPP): Global healthcare communications agency within WPP, offering PR, medical communications, public affairs, and patient engagement; competes with LaVoieHealthScience for mid- and large-cap health clients where global scale and integrated capabilities are required.
• Edelman: Largest global PR firm with a dedicated health practice (Edelman Health) serving pharmaceutical, biotech, medtech, and consumer health clients; competes for senior-level communications mandates that LaVoie also targets, particularly for global program scope.
• Syneos Health Communications: Integrated biopharmaceutical solutions organization with healthcare communications offerings spanning PR, medical affairs, and patient engagement; competes with LaVoieHealthScience for clinical-stage and commercial-stage biotech communications programs.
• Ogilvy Health (WPP): Global healthcare marketing and communications network within WPP, where former LaVoie team member Harriet Ullman previously served; competes directly with LaVoieHealthScience for pharmaceutical and biotech product communications mandates at larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/LaVoieGroup
• Facebookfacebook.com/LaVoieGroup
• LinkedInlinkedin.com/company/lavoiehealthscience

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LaVoie Strategic Communications Group